Change - Announcement of Cessation::RESIGNATION OF CHIEF OPERATING OFFICER

Issuer & Securities

Issuer/ Manager
HC SURGICAL SPECIALISTS LIMITED
Securities
HC SURGICAL SPECIALISTSLIMITED - SG1DC2000004 - 1B1
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
14-Feb-2022 20:24:14
Status
New
Announcement Sub Title
RESIGNATION OF CHIEF OPERATING OFFICER
Announcement Reference
SG220214OTHR1QRK
Submitted By (Co./ Ind. Name)
Dr. Heah Sieu Min
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Ms. Ouyang Yuxia, Connie has tendered her resignation as Chief Operating Officer and her last working day with the Company is on 30 April 2022. Her duties will be covered by Ms. Melissa Josephine Tio @ Melissa Josephine Susantio, the existing Operations, Marketing and IT Manager.

HC Surgical Specialists Limited (the "Company") was incorporated on 1 September 2015 in Singapore and listed on Catalist of the Singapore Exchange Securities Trading Limited on 3 November 2016. The Company, its subsidiaries and associated company are a medical services group primarily engaged in the provision of endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services with a focus on colorectal procedures across a network of 16 clinics located throughout Singapore.

This announcement has been prepared by the Company and reviewed by the Company's sponsor, Novus Corporate Finance Pte. Ltd. (the "Sponsor"), in compliance with Rule 226(2)(b) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made, or reports contained in this announcement.

The contact person for the Sponsor is Mr. Pong Chen Yih, Chief Operating Officer, at 7 Temasek Boulevard, #18-03B Suntec Tower 1, Singapore 038987, telephone (65) 6950 2188.

Additional Details

Name Of Person
Ouyang Yuxia, Connie
Age
38
Is effective date of cessation known?
Yes
If yes, please provide the date
01/05/2022
Detailed Reason (s) for cessation
Ms. Ouyang Yuxia, Connie has resigned to pursue other career opportunities.

After having interviewed Ms. Ouyang Yuxia, Connie and to the best of its knowledge, the Company's sponsor, Novus Corporate Finance Pte. Ltd. is satisfied that save as disclosed in this announcement, there are no other material reasons for the resignation of Ms. Ouyang Yuxia, Connie as Chief Operating Officer of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
01/06/2017
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
1
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Operating Officer
Role and responsibilities
As Chief Operating Officer, Ms. Ouyang Yuxia, Connie is responsible for the overall operation of the Group's clinics, including ensuring that every clinic conforms to a common operating procedure and process, and adheres to stringent standard of procedures, clinical guidelines and safety procedures.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
51,100 ordinary shares
Past (for the last 5 years)
None
Present
None